Blog

Pharma Journal Blog

All about the Pharmaceutical industry in the UK and the world.
Abiraterone

NHS England has widened abiraterone acetate access for adults with high-risk non-metastatic prostate cancer, with treatment expected to reach eligible patients within weeks. The change...

pharmacogenomics, NHS prescribing, genomic medicine,

The NHS has entered a decisive phase in the use of pharmacogenomics, moving from targeted pilots to routine medicines optimisation informed by genetic data. By...

CRISPR Therapies, Gene Editing Cancer, Allogeneic CAR t

The first regulatory approvals for a CRISPR-based medicine in the UK and EU marked a turning point for genomic medicine and set expectations for oncology....

Pharma AI

In 2026, the pharmaceutical sector is moving back into a risk on posture, with AI drug discovery shifting from promise to operational impact and a...

uk clinical trials, phase i research, participant compensation

The United Kingdom enters 2026 as one of the most active environments in the world for high-paying clinical trials, particularly early phase studies involving healthy...

Cathepsin B, CTSB inflammasome activation, CTSB antigen processing

Cathepsin B (CTSB) is a lysosomal cysteine protease that plays a key role in protein turnover, antigen processing, and immune regulation. It is widely expressed...

For over a century, the discovery of insulin transformed Type 1 Diabetes (T1D) from a fatal diagnosis into a survivable condition. Yet, despite remarkable technological...

Cytotoxic T Cells

The human immune system is a complex network of cells, tissues, and signaling molecules that serves as a defense system. It continuously identifies and eliminates...

digital therapeutics NHS, dtx uk, nice digital framework

Chronic illness drives demand across the NHS and shapes budgets, workforce planning and service design. People living with multiple long-term conditions account for around half...

bacteriophage therapy, antimicrobial resistance, phage cocktails

Antimicrobial resistance is accelerating across health systems and undermining routine care. Surgical prophylaxis, oncology regimens and neonatal medicine all depend on reliable antibiotics, yet resistant...

stem cell, anthony nolan, donor register

For patients living with blood cancer or a severe blood disorder, a stem cell transplant is often the turning point between decline and recovery. Yet...

community pharmacy, chronic care, medicines shortages

Community pharmacy in the UK has entered a decisive phase. Policy, funding, and data infrastructure now point to a model where pharmacies act as clinical...